356 related articles for article (PubMed ID: 15695476)
21. Ascorbic acid in the prevention and treatment of cancer.
Head KA
Altern Med Rev; 1998 Jun; 3(3):174-86. PubMed ID: 9630735
[TBL] [Abstract][Full Text] [Related]
22. The effects of mega-dose ascorbic acid on skin flap survival: experimental study on rats.
Kwon ST; Jeong JH; Eun SC; Baek RM; Minn KW; Heo CY
J Plast Reconstr Aesthet Surg; 2009 Dec; 62(12):e641-2. PubMed ID: 19188104
[No Abstract] [Full Text] [Related]
23. [Vitamin C: antioxidant barrier].
Kleszczewska E
Pol Merkur Lekarski; 2001 Jun; 10(60):483-6. PubMed ID: 11503271
[TBL] [Abstract][Full Text] [Related]
24. Integrating pain metrics into oncology clinical trials.
Cleeland CS; O'Mara A; Zagari M; Baas C
Clin Cancer Res; 2011 Nov; 17(21):6646-50. PubMed ID: 22046026
[TBL] [Abstract][Full Text] [Related]
25. Ascorbic acid revisited.
Fulghum DD
Arch Dermatol; 1977 Jan; 113(1):91-2. PubMed ID: 318818
[No Abstract] [Full Text] [Related]
26. Effect of alpha-tocopherol and ascorbic acid on bovine oocyte in vitro maturation.
Dalvit G; Llanes SP; Descalzo A; Insani M; Beconi M; Cetica P
Reprod Domest Anim; 2005 Apr; 40(2):93-7. PubMed ID: 15819954
[TBL] [Abstract][Full Text] [Related]
27. Ascorbic acid protects against lipopolysaccharide-induced intra-uterine fetal death and intra-uterine growth retardation in mice.
Chen YH; Xu DX; Zhao L; Wang H; Wang JP; Wei W
Toxicology; 2006 Jan; 217(1):39-45. PubMed ID: 16171921
[TBL] [Abstract][Full Text] [Related]
28. Parenteral vitamin C for palliative care of terminal cancer patients.
Carr AC; Vissers MC; Cook J
N Z Med J; 2014 Jun; 127(1396):84-6. PubMed ID: 24997468
[No Abstract] [Full Text] [Related]
29. Combining ursodeoxycholic acid or its NO-releasing derivative NCX-1000 with lipophilic antioxidants better protects mouse hepatocytes against amiodarone toxicity.
Ouazzani-Chahdi A; Elimadi A; Chabli A; Spénard J; Colin P; Haddad PS
Can J Physiol Pharmacol; 2007 Feb; 85(2):233-42. PubMed ID: 17487265
[TBL] [Abstract][Full Text] [Related]
30. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer.
Cameron E; Campbell A
Chem Biol Interact; 1974 Oct; 9(4):285-315. PubMed ID: 4430016
[No Abstract] [Full Text] [Related]
31. [The effectiveness of ascorbic acid and emoxipin in treatment of infiltrative pulmonary tuberculosis].
Volchegorskiĭ IA; Novoselov PN; Astakhova TV
Klin Med (Mosk); 2007; 85(12):55-8. PubMed ID: 18318169
[TBL] [Abstract][Full Text] [Related]
32. Ascorbic acid (Vitamin C) in the treatment of cancer.
J Med Soc N J; 1980 Jan; 77(1):49. PubMed ID: 6928213
[No Abstract] [Full Text] [Related]
33. Ascorbic acid in the prevention and treatment of cancer.
Mata AM; Carvalho RM; Alencar MV; Cavalcante AA; Silva BB
Rev Assoc Med Bras (1992); 2016 Oct; 62(7):680-686. PubMed ID: 27925049
[TBL] [Abstract][Full Text] [Related]
34. Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission.
Binfaré RW; Rosa AO; Lobato KR; Santos AR; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):530-40. PubMed ID: 19439241
[TBL] [Abstract][Full Text] [Related]
35. Opioids and cancer survivors: issues in side-effect management.
Palos GR
Oncol Nurs Forum; 2008 Nov; 35 Suppl():13-9. PubMed ID: 18980935
[TBL] [Abstract][Full Text] [Related]
36. New insights into the physiology and pharmacology of vitamin C.
Padayatty SJ; Levine M
CMAJ; 2001 Feb; 164(3):353-5. PubMed ID: 11232136
[No Abstract] [Full Text] [Related]
37. Can ageing-related degenerative diseases be ameliorated through administration of vitamin C at pharmacological levels?
Li Y; Schellhorn HE
Med Hypotheses; 2007; 68(6):1315-7. PubMed ID: 17141419
[TBL] [Abstract][Full Text] [Related]
38. Vitamin C: research update.
Bruno EJ; Ziegenfuss TN; Landis J
Curr Sports Med Rep; 2006 Jun; 5(4):177-81. PubMed ID: 16830410
[TBL] [Abstract][Full Text] [Related]
39. Ascorbic acid supplementation could affect passive avoidance learning and memory in rat.
Shahidi S; Komaki A; Mahmoodi M; Atrvash N; Ghodrati M
Brain Res Bull; 2008 May; 76(1-2):109-13. PubMed ID: 18395619
[TBL] [Abstract][Full Text] [Related]
40. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Res Commun Mol Pathol Pharmacol; 2004; 115-116():251-64. PubMed ID: 17564322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
